Select Language
Free Registration

NRTN

Product Inquiry

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
ArfolitixorinISO-901; 6R-MTHFPhase 3 ClinicalIsofol Medical AbRectal Neoplasms; Colonic Neoplasms; Osteosarcoma; Colorectal Neoplasms
Details
Luveltamab tazevibulinSTRO-002Phase 3 ClinicalSutro Biopharma IncSolid tumours; Ovarian Neoplasms; Carcinoma, Ovarian Epithelial; Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Endometrial Neoplasms; Carcinoma, Endometrioid
Details
CBP-1008CBP-1008Phase 2 ClinicalSolid tumours; Ovarian Neoplasms; Carcinoma, Ovarian Epithelial; Breast Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Squamous Cell
Details
FarletuzumabMORAb-003Phase 2 ClinicalMorphotek IncOvarian Neoplasms; Solid tumours; Neoplasms; Carcinoma, Ovarian Epithelial; Adenocarcinoma of Lung; Peritoneal Neoplasms; Fallopian Tube Neoplasms
Details
Rinatabart SesutecanPRO-1184Phase 2 ClinicalProfoundBio (Suzhou) Co LtdSolid tumours; Ovarian Neoplasms; Triple Negative Breast Neoplasms; Mesothelioma; Breast Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Endometrial Neoplasms; Carcinoma, Non-Small-Cell Lung
Details
ELU-001ELU-001Phase 2 ClinicalElucida Oncology IncOvarian Neoplasms; Uterine Diseases; Carcinoma, Ovarian Epithelial; Ovarian Diseases; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Endometrial Neoplasms; Leukemia, Myeloid, Acute; Carcinoma, Endometrioid; Neoplasm Metastasis; Adenocarcinoma
Details
AZD5335AZD5335; AZD-5335Phase 2 ClinicalAstrazeneca PlcOvarian Neoplasms; Solid tumours; Adenocarcinoma of Lung
Details
Farletuzumab ecteribulinMORAb-202Phase 2 ClinicalMorphotek Inc, Bristol-Myers Squibb Company, Eisai Co LtdSolid tumours; Ovarian Neoplasms; Carcinoma, Non-Small-Cell Lung
Details
BAT-8006BAT8006; BAT-8006Phase 2 ClinicalBio-Thera Solutions LtdSolid tumours; Ovarian Neoplasms; Carcinoma, Ovarian Epithelial; Peritoneal Neoplasms; Fallopian Tube Neoplasms
Details
4S-CAR-FRa4S-CAR-FRaPhase 2 ClinicalShenzhen Geno-Immune Medical InstituteCarcinoma, Transitional Cell; Urinary Bladder Neoplasms
Details
Noscapine-folate conjugatePhase 1 ClinicalEmory UniversityHematologic Neoplasms; Inflammation
Details
MOv-18 IgEMOv-18 IgE; MOv18; MOv-18Phase 1 ClinicalKing'S College London, Cancer Research UKOvarian Neoplasms; Neoplasms
Details
ITIL-306ITIL-306Phase 1 ClinicalInstil Bio IncSolid tumours; Carcinoma, Renal Cell; Carcinoma, Ovarian Epithelial; Genital Neoplasms, Female; Carcinoma, Non-Small-Cell Lung
Details
IMGN-151IMGN-151Phase 1 ClinicalImmunogen IncOvarian Neoplasms; Cystadenocarcinoma, Serous; Breast Neoplasms; Peritoneal Neoplasms; Endometrial Neoplasms; Fallopian Tube Neoplasms; Uterine Cervical Neoplasms
Details
ZW-191ZW-191Phase 1 ClinicalZymeworks IncSolid tumours; Ovarian Neoplasms; Genital Neoplasms, Female; Carcinoma, Non-Small-Cell Lung
Details
AMT-151AMT-151Phase 1 ClinicalMultitude Therapeutics IncSolid tumours; Ovarian Neoplasms; Adenocarcinoma of Lung; Neoplasms; Triple Negative Breast Neoplasms; Carcinoma, Ovarian Epithelial; Mesothelioma; Adenocarcinoma, Clear Cell; Peritoneal Neoplasms; Carcinoma, Pancreatic Ductal; Endometrial Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Endometrioid; Adenocarcinoma
Details
UB-TT170UB-TT170; UB-TT-170; UB_TT170; UB_TT-170Phase 1 ClinicalUmoja BioPharma IncOsteosarcoma
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyEarliest Brand NameEarliest Approval CountryEarliest IndicationEarliest Approval CompanyEarliest Approval DateIndicationClinical Trial
Pafolacianine SodiumPteroyl-L-Tyr-S0456; OTL-38; EC-17; OTL-0038ApprovedOn Target Laboratories IncCytaluxUnited StatesOvarian NeoplasmsOn Target Laboratories Inc2021-11-29Ovarian Neoplasms; Inflammatory Bowel Diseases; Neoplasms; Arthritis, Rheumatoid; Breast Neoplasms; Pituitary Neoplasms; Peritoneal Neoplasms; Lung Neoplasms; Gastrointestinal Neoplasms
Details
Mirvetuximab soravtansineTAK-853; M9346-Asulfo-SPDB-DM4; IMGN-853; M9346A-sSPDB-DM4ApprovedImmunogen IncElahereUnited StatesPeritoneal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Ovarian EpithelialImmunogen Inc2022-11-14Ovarian Neoplasms; Solid tumours; Fallopian Tube Diseases; Cystadenoma, Serous; Carcinoma, Ovarian Epithelial; Neoplasms; Triple Negative Breast Neoplasms; Breast Neoplasms; Adenocarcinoma, Clear Cell; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Endometrial Neoplasms; Carcinosarcoma; Uterine Neoplasms; Peritoneal Diseases
Details
Folinic AcidFTHFApprovedAutism Spectrum Disorder; Down Syndrome; Rectal Neoplasms; Anemia; Diarrhea; Vitamin B 12 Deficiency; Colorectal Neoplasms
Details
  • Product Inquiry
  • Marketed Drug Information
  • Clinical Drug Information
Share to:

Join UsLegalSite MapPrivacy PolicyTerms and Conditions
Website Feedback
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

order@acrobiosystems.com

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland